EU regulator backs mRNA vaccine booster for people with weak immunity
People with a severely weakened immune system should be given a third dose of the Pfizer-BioNTech and Moderna vaccines
The European Union's drugs regulator said on Monday people with weakened immune systems should get a third dose of a COVID-19 vaccine from Pfizer-BioNTech or Moderna, but left it to member states to decide if the wider population should have a booster, Qazet.az reports citing Reuters.
The long-awaited guidance comes after several EU member states pre-empted the European Medicines Agency's (EMA) opinion and launched their own booster campaigns, although they vary widely over who is eligible.
The EU joins the United States, Britain and Israel where regulators have approved the use of Pfizer-BioNTech boosters, although there is no consensus among scientists about how broadly they should be rolled out. Israel is the outlier, deploying them across the whole population.
The EMA said people with a severely weakened immune system should be given a third dose of the Pfizer-BioNTech and Moderna vaccines - both based on so-called mRNA technology - at least 28 days after their second one.